CorMedix Inc (NASDAQ:CRMD) shares, rose in value on Wednesday, April 16, with the stock price up by 1.62% to the previous day’s close as strong demand from buyers drove the stock to $7.52.
Actively observing the price movement in the last trading, the stock closed the session at $7.40, falling within a range of $7.075 and $7.5394. The value of beta (5-year monthly) was 1.566. Referring to stock’s 52-week performance, its high was $13.85, and the low was $3.61. On the whole, CRMD has fluctuated by -27.90% over the past month.
With the market capitalization of CorMedix Inc currently standing at about $490.17 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 133.93M, with a low estimate of 38.7M and a high estimate of 39M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 38.9M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRMD’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of CRMD currently trading nearly 2.56% and -17.96% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.98, while the 7-day volatility ratio is showing 5.09% which for the 30-day chart, stands at 8.37%. Furthermore, CorMedix Inc (CRMD)’s beta value is 1.52, and its average true range (ATR) is 0.62.
A comparison of CorMedix Inc (CRMD) with its peers suggests the former has fared considerably weaker in the market. CRMD showed an intraday change of 1.62% in last session, and over the past year, it grew by 39.78%%.
Data on historical trading for CorMedix Inc (NASDAQ:CRMD) indicates that the trading volumes over the past 10 days have averaged 1.58 and over the past 3 months, they’ve averaged 1.42 million. According to company’s latest data on outstanding shares, there are 64.41 million shares outstanding.
Nearly 8.59% of CorMedix Inc’s shares belong to company insiders and institutional investors own 35.11% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.92 million shares as on 2025-03-31, resulting in a short ratio of 3.97. According to the data, the short interest in CorMedix Inc (CRMD) stood at 1217.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 7.88 million. The stock has fallen by -7.16% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRMD stock heading into the next quarter.
